| Title |
The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review
|
|---|---|
| Published in |
CNS Drugs, April 2018
|
| DOI | 10.1007/s40263-018-0517-5 |
| Pubmed ID | |
| Authors |
Per Damkier, Poul Videbech |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ireland | 2 | 25% |
| Argentina | 1 | 13% |
| Colombia | 1 | 13% |
| France | 1 | 13% |
| Unknown | 3 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 50% |
| Scientists | 2 | 25% |
| Practitioners (doctors, other healthcare professionals) | 2 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 124 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 12% |
| Student > Bachelor | 15 | 12% |
| Student > Master | 12 | 10% |
| Other | 11 | 9% |
| Student > Doctoral Student | 10 | 8% |
| Other | 24 | 19% |
| Unknown | 37 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 35% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 7% |
| Psychology | 8 | 6% |
| Neuroscience | 8 | 6% |
| Nursing and Health Professions | 5 | 4% |
| Other | 10 | 8% |
| Unknown | 40 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2022.
All research outputs
#2,114,536
of 25,837,817 outputs
Outputs from CNS Drugs
#154
of 1,403 outputs
Outputs of similar age
#43,892
of 346,534 outputs
Outputs of similar age from CNS Drugs
#7
of 21 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,403 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,534 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.